Participated · Series B · Dec 2025

pH7 Technologies operates a commercial PGM extraction facility in Vancouver and is scaling its mining-sector applications beginning with copper. Its proprietary closed-loop organo-electrochemical process is designed to recover metals from low-grade sulfide ore, tailings, and complex feedstocks that have been historically uneconomic or challenging to process. The company’s proposed copper production approach aims to convert low-grade sulfide ore directly into 99.9% pure copper cathodes on-site while generating green hydrogen as a by-product. pH7 says the process could increase recovery from low-grade resources, extend the value of existing mining assets, and strengthen domestic critical mineral supply chains. Current plans include engineering and technology development phases to produce technical and economic data to support future demonstration and commercial deployment across the Canadian mining sector.

Participated · Seed · Apr 2025

DePoly develops a chemical recycling process that breaks PET and polyester plastics down to their original monomers without using fossil fuels. The company raised a $23M Seed round to fund a 500-tonne-per-year showcase plant in Monthey, Switzerland, scheduled to open in summer 2025. The showcase plant is intended to demonstrate the technology at industrial scale and validate DePoly’s roadmap toward a circular plastics market. Investors in the round include a strategic investment from MassMutual Ventures alongside BASF Venture Capital, Beiersdorf Venture Capital, and Zürcher Kantonalbank. DePoly has collaborations with Odlo, PTI, and Beiersdorf across fashion, consumer goods, and cosmetics. Management highlights in the articles include Co-Founder and CEO Samantha Anderson and CFO David Hanf, who joined in 2024, and the company plans to refine its technology and pursue a commercial-scale plant to process larger volumes and compete with virgin pricing at scale. DePoly uses a chemical recycling process to convert PET plastics and polyester textiles back into their original monomers (PTA and MEG). Its room-temperature, standard-pressure process requires no washing, pre-sorting, or melting and can handle contaminated, mixed-color, and textile waste streams that mechanical recycling cannot. The company currently operates a pilot plant that processes 50 tons per year and serves industries including post-consumer packaging, textiles, fashion, and post-industrial streams; it reports five customers. DePoly is building a 500-ton showcase plant to demonstrate commercial scale and is scaling its technology to recover other materials such as PP, cotton, polyurethanes (PU), polylactic acid (PLA), and PBT. Founded in 2020 by Samantha Anderson, Bardiya Valizadeh and Christopher Ireland, the company has a team of 13 people. It sells recovered raw chemical components back to manufacturers, positioning its output as virgin quality to enable a circular economy for plastics. DePoly is an EPFL spin-off chemical-technology startup that converts low-value PET waste into high-value chemical monomers like TPA to enable a circular economy. It has developed a depolymerization process that returns PET to its two main chemical components identical in quality to oil-derived raw materials. The process operates at room temperature without applied pressure and uniquely tolerates mixed plastics (PET with PVC, PP, PS, etc.), mixed colors, dirty PET, and fabrics/fibers. DePoly sells the recovered monomers back to industry as feedstock for PET production. With the CHF1.3M pre-seed financing, the company will develop an enhanced recycling pre-demo plant to depolymerize PET into the raw materials required for PET production. DePoly has also been supported by Venture Kick and TOP 100. DePoly has developed a chemical recycling process that selectively treats PET in mixed plastic waste to produce chemical intermediates usable to make 100% recycled PET resins. The process works at room temperature without added heat or pressure, handles mixed colour, multi‑layer and polyester fibre PET, and uses sustainable, environmentally friendly chemicals. DePoly says every ton recycled saves energy equivalent to four European households’ annual electricity use, 18 barrels of oil, or ten London–New York passenger flights. The company collaborates with EPFL Valais‑Wallis and was founded in February 2020 by Samantha Anderson, Christopher Ireland and Bardiya Valizadeh. It has received support from VentureKick, Climate‑KIC, EPFL, Venture and CleanTechAlps and is currently conducting a seed fundraising round to build a larger demo plant. The recently awarded FIT Tech Seed loan will fund a 10 kg pilot plant footprint and help cover staff salaries to operate the unit. With those plants, DePoly targets PET resin producers, plastic recyclers and chemical industry customers.

Led · Series A · Feb 2025

ACT-ion Battery Technologies develops coated single-crystal cathode active materials (CAMs) for lithium batteries using a rapid continuous, clean, and chemistry-agnostic manufacturing process that aims to lower energy use and cost. The company is led by CEO Jin Lim and is based in Dallas, Texas. It is building and commissioning a pilot production facility in Carrollton, Texas, to scale its CAM production. ACT-ion intends to use recent funds to complete the pilot build-out and to secure commercial validation and offtake agreements with partners in the electric vehicle and energy storage sectors. Financially, the company recently closed a $4M Pre‑Series A extension led by Kyobo Life Insurance Group and KB Investment. That $4M followed an initial $7.5M close with participation from BASF Venture Capital, Hunt Energy Enterprises, Arosa Capital, Mirae Asset Capital, and LG Technology Ventures, bringing total disclosed funding to $11.5M. ACT-ion develops lithium battery cathode active material (CAM) production technology using a rapid continuous process that yields coated single crystal CAMs through a clean, chemistry-agnostic method requiring lower energy and cost. The company was incubated within and spun out of Hunt Energy Enterprises LLC. Led by Jin Lim, CTO and Interim CEO, ACT-ion has successfully demonstrated its manufacturing platform for a variety of chemistries. The company is based in Dallas, Texas. ACT-ion intends to use new funding to accelerate its CAM production technology and to establish an operational pilot facility by 2025, with validations from industry partners. The article reports a $7.5M fundraising, indicating early-stage capital to commercialize the platform.

Participated · Series A · Apr 2024

Founded in 2015 and headquartered in Zhuhai, Guangyu Technology develops and industrializes photonic crystal metamaterials and nano/micro-sphere functional units. The company has built a full-stack, in-house production process from core–shell polymer microsphere synthesis to large-area, industrial manufacturing. Its platform enables high-throughput, continuous, wide-format and low-cost production of photonic crystal effect pigments and films that are solvent- and metal-free. Products target applications across consumer electronics, home appliances, automotive, photovoltaics and construction, with over 50 product designs and partnerships with leading customers. The company operates a production center with annual capacity exceeding 400 tonnes and plans to expand to kiloton-level output following the financing. Guangyu emphasizes environmentally friendly processing, high transmittance, and broad material/process compatibility to replace traditional metal-oxide effect pigments in multiple commercial scenarios.

Participated · Series B · Sep 2022

InsideTracker is a Cambridge, MA-based healthspan optimization platform that integrates biomarker data from blood, DNA, activity trackers, and user demographics to deliver science-backed recommendations to help users live healthier longer. The platform is powered by a proprietary AI engine that combines machine learning and computational biology with more than 60,000 human-hours of meta-analysis and curation from the company’s cross-disciplinary team. Ongoing research, development, and calibration of the engine is led by Renee Deehan, PhD, Vice President of Science and Artificial Intelligence, and Gil Blander, PhD, Founder and Chief Scientific Officer, with scientific advisory board members including Eran Segal and Ali Torkamani. The company is led by Rony Sellam. In September 2022 InsideTracker raised $15M in a Series B funding round led by PeakBridge with participation from Cornucopian Capital, OurCrowd, BASF Venture Capital GmbH, and existing investors. The company intends to use the funds to expand operations and its business reach. Segterra offers InsideTracker, a platform that begins with a blood test (lab draw or mailed home kit) to identify biomarkers and then provides personalized recommendations based on nutrition and demographic databases and academic research. The product targets health-conscious users and historically served professional and amateur athletes, but the company is positioning its latest iteration for a broader consumer audience. InsideTracker provides tiered plans: a $49 upload-only option, a $149 fitness plan (12 biomarkers), a $299 performance plan (20 biomarkers), and a $499 ultimate plan (30 biomarkers). Results are delivered online about five to seven days after a blood draw, and Segterra currently partners exclusively with LabCorp for testing; it also offers optional in-home or on-site phlebotomy. The team includes scientists, providers, nutritionists, and exercise physiologists from MIT, Harvard, and Tufts. Segterra has 11 employees and recently partnered with fitness chain Sports Club/LA to promote the platform.